A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of VX-407 in Healthy Participants

Conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Interventions: Drug: VX-407; Drug: Placebo; Drug: Midazolam Sponsors: Vertex Pharmaceuticals Incorporated Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials